Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis

Overview of attention for article published in Breast Cancer Research and Treatment, May 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 5,052 followers.

Cribado #VHB antes de quimioterapia adyuvante en #cáncer_mama: análisis de coste-efectividad http://t.co/2vvI6K5R3m @sepdigestiva @sapdes

Cribado #VHB antes de quimioterapia adyuvante en #cáncer_mama: análisis de coste-efectividad http://t.co/2vvI6K5R3m @sepdigestiva @sapdes

Cribado #VHB antes de quimioterapia adyuvante en #cáncer_mama: análisis de coste-efectividad http://t.co/2vvI6K5R3m @sepdigestiva @sapdes

Cost-effective HBV screening before chemo significantly prevents reactivations http://t.co/XtmiPGRuty via @thetacollab #HTAC

Cost-effective HBV screening before chemotherapy significantly prevents re-activations, may extend lives @thetacollab http://t.co/sa9uerVZLj

Cost-effective HBV screening before chemotherapy significantly prevents re-activations, may extend lives @thetacollab http://t.co/sa9uerVZLj